Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024

Biodesix, Inc. , a leading diagnostic solutions company with a focus in lung disease, announced today that it will release financial results for the fourth quarter and year ended December 31, 2023...

Related Keywords

,Biodesix Inc ,Nasdaq ,Nodify Lung ,Diagnostic Cortex ,Artificial Intelligence ,Private Securities Litigation Reform Act ,Risk Factors ,Markets ,